SC
Searle & Co Portfolio holdings
AUM
$354M
This Quarter Return
+1.04%
1 Year Return
+16.26%
3 Year Return
+62.13%
5 Year Return
+132.53%
10 Year Return
+233.89%
AUM
$118M
AUM Growth
–
Cap. Flow
+$118M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
29.66%
Holding
377
New
375
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Exxon Mobil
XOM
|
$7.93M |
| 2 |
Bank of America
BAC
|
$3.79M |
| 3 |
IBM
IBM
|
$3.74M |
| 4 |
Bristol-Myers Squibb
BMY
|
$3.72M |
| 5 |
Johnson & Johnson
JNJ
|
$3.65M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 23.23% |
| 2 | Energy | 19.3% |
| 3 | Industrials | 9.54% |
| 4 | Technology | 8.54% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exxon Mobil
XOM
$487B
| $7.93M | 6.71% |
+85,734
| New | +$7.93M |
|
|
2
Bank of America
BAC
$376B
| $3.79M | 3.21% |
+211,950
| New | +$3.79M |
|
|
3
IBM
IBM
$227B
| $3.74M | 3.17% |
+23,330
| New | +$3.74M |
|
|
4
Bristol-Myers Squibb
BMY
$96B
| $3.72M | 3.14% |
+62,950
| New | +$3.72M |
|
|
5
Johnson & Johnson
JNJ
$427B
| $3.65M | 3.09% |
+34,900
| New | +$3.65M |
|
6
CVS Health
CVS
$92.8B
| $2.7M | 2.29% |
+28,060
| New | +$2.7M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $2.46M | 2.08% |
+9,572
| New | +$2.46M |
|
8
Philip Morris
PM
$260B
| $2.45M | 2.07% |
+30,056
| New | +$2.45M |
|
9
Baxter International
BAX
$12.7B
| $2.38M | 2.01% |
+32,500
| New | +$2.38M |
|
10
Yum! Brands
YUM
$40.8B
| $2.23M | 1.89% |
+30,600
| New | +$2.23M |
|
11
Honeywell
HON
$139B
| $1.96M | 1.66% |
+19,651
| New | +$1.96M |
|
|
BPL
12
DELISTED
Buckeye Partners, L.P.
BPL
| $1.91M | 1.62% |
+25,250
| New | +$1.91M |
|
13
McDonald's
MCD
$224B
| $1.86M | 1.58% |
+19,900
| New | +$1.86M |
|
14
Walt Disney
DIS
$213B
| $1.77M | 1.5% |
+18,800
| New | +$1.77M |
|
|
MMP
15
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.69M | 1.43% |
+20,500
| New | +$1.69M |
|
16
Visa
V
$683B
| $1.63M | 1.38% |
+6,225
| New | +$1.63M |
|
17
Procter & Gamble
PG
$368B
| $1.52M | 1.29% |
+16,725
| New | +$1.52M |
|
18
Merck
MRK
$210B
| $1.44M | 1.22% |
+25,362
| New | +$1.44M |
|
19
Sanofi
SNY
$121B
| $1.43M | 1.21% |
+31,300
| New | +$1.43M |
|
20
AstraZeneca
AZN
$248B
| $1.38M | 1.17% |
+19,650
| New | +$1.38M |
|
|
HES
21
DELISTED
Hess
HES
| $1.37M | 1.16% |
+18,609
| New | +$1.37M |
|
22
Gilead Sciences
GILD
$140B
| $1.36M | 1.15% |
+14,400
| New | +$1.36M |
|
|
XIFR
23
XPLR Infrastructure, LP
XIFR
$996M
| $1.36M | 1.15% |
+40,200
| New | +$1.36M |
|
|
DD
24
DELISTED
Du Pont De Nemours E I
DD
| $1.33M | 1.13% |
+18,046
| New | +$1.33M |
|
25
Boeing
BA
$177B
| $1.31M | 1.11% |
+10,100
| New | +$1.31M |
|